Conference-FASEB Growth Factor Receptor Tyrosine Kinases

会议-FASEB生长因子受体酪氨酸激酶

• 批准号: 6774814
• 负责人: William Muller
• 金额: $ 0.9万
• 依托单位: FEDERATION OF AMER SOC FOR EXPER BIOLOGY
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-08-01 至 2008-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6774814
• 关键词: carcinogenesis; growth factor receptors; histogenesis; meeting /conference /symposium; mitogens; neoplastic process; protein structure function; protein tyrosine kinase; travel

DESCRIPTION (provided by applicant): We seek partial support for the third in a series of FASEB Summer Research Conferences on "Growth Factor Receptor Tyrosine Kinases I Mitogenesis, Morphogenesis, and Tumorigenesis", to be held in Tucson AZ from August 2 to August 7, 2003. This conference will build upon the success of the two earlier conferences held in 1999 and 2001, and continue to focus on new developments in biology and pathophysiology of important classes of growth factor receptor tyrosine kinases as they relate to mitogenesis, development, morphogenesis, tumorigenesis and tumor progression. Because of the overwhelming breadth of the tyrosine kinase field, consistent with earlier meetings we will maintain some emphasis on recent developments relevant to ErbB and Met families of receptor tyrosine kinases. However, the sessions on developmental systems have been expanded to include invertebrate receptor signaling paradigms, since these systems lead the way on understanding integrative mechanisms of receptor signaling. For these, and other unique receptor kinase signaling paradigms, we will broaden the scope beyond these receptors. A new session, including plenary talk, has been added to discuss the important and topical question of signal specification by receptor tyrosine kinases. The Scientific Program will include platform presentations by 26 invited speakers, internationally renowned leaders in their respective areas. The program will also include a significant number of oral presentations selected from the Abstracts, and also Poster Sessions to showcase work by all attendees. A Young Investigator Mini-Symposium, which was a highlight of the previous conferences, will be featured. In order to maximize scientific interactions among participants, conference attendance will be limited to 100-190 investigators including invited speakers and individuals selected from the conference applications. We will endeavor to provide a mix of established and junior investigators, with participation by women and minorities encourage. We anticipate that this conference will succeed in serving as a forum for state-of-the-art scientific interchange on growth factor receptor tyrosine kinases. It will foster new collaborative enterprises, and maintain the high standards appropriate to the FASEB Conference series.

描述（由申请人提供）：我们在8月2日至8月7日在图森AZ举行了一系列关于“生长因子受体酪氨酸激酶I I有丝分裂，形态发生和肿瘤发生”的FaseB夏季研究会议的部分支持的部分支持。 ，2003年。这次会议将基于1999年和2001年举行的两个早期会议的成功，并继续专注于重要类别的生长因子受体酪氨酸激酶的生物学和病理生理学的新发展，因为它们与有丝分裂，发展，形态发生，形态发生有关，肿瘤发生和肿瘤进展。 由于酪氨酸激酶领域的压倒性广度，与较早的会议一致，我们将一致地强调与ERBB相关的最新发展，并遇到了受体酪氨酸激酶的家族。 但是，关于发育系统的会话已扩展到包括无脊椎动物受体信号传导范例，因为这些系统导致理解受体信号的综合机制。 对于这些以及其他独特的受体激酶信号传导范例，我们将扩大这些受体之外的范围。 已经添加了包括全体会议在内的新会议，以讨论受体酪氨酸激酶的信号规范的重要和主题问题。 科学计划将包括26位受邀演讲者，国际知名领导人的平台演讲。 该计划还将包括大量从摘要中选择的口头演示文稿，以及展示所有与会者工作的海报会议。 一位年轻的调查员迷你群岛将是以前会议的亮点，将会出现。 为了使参与者之间的科学互动最大化，会议出勤率将限于100-190名调查人员，包括受邀的演讲者和从会议申请中选出的个人。 我们将努力提供成熟和初级调查人员的混合，并鼓励妇女和少数群体的参与。 我们预计，这次会议将成功地作为生长因子受体酪氨酸激酶的最先进科学互换论坛。 它将培养新的合作企业，并保持适合FaseB会议系列的高标准。